Insider · CIK 0001944355

Welch Stephen Andrew

Reports to the SEC for 1 company · HAZELWOOD, MO

sec.gov

Transactions

Companies

Filings

CIK

0001944355

Forms 4 and 5

Insider transactions

12 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-11-10	Keenova Therapeutics plcRestricted Stock UnitsD Disposition to Issuer	EVP & Head of Spec Generics	DDisposition to Issuer	+43.8K sh	—	—	0
2025-07-31	Keenova Therapeutics plcRestricted Stock UnitsA Award	EVP & Head of Spec Generics	AAward	+32.8K sh	—	—	43,771
2025-01-01	Keenova Therapeutics plcM Exercise/Conversion	EVP & Head of Spec Generics	MExercise/Conversion	+5,470 sh	—	—	5,470
2025-01-01	Keenova Therapeutics plcF Tax Payment	EVP & Head of Spec Generics	FTax Payment	−1,839 sh	—	—	3,631
2025-01-01	Keenova Therapeutics plcRestricted Stock UnitsM Exercise/Conversion	EVP & Head of Spec Generics	MExercise/Conversion	−5,470 sh	—	—	10,943
2024-02-02	Keenova Therapeutics plcRestricted Stock UnitsA Award	EVP & Head of Spec Generics	AAward	−16.4K sh	—	—	16,413
2023-11-14	Keenova Therapeutics plcD Disposition to Issuer	EVP & Head of Spec Generics	DDisposition to Issuer	−32.7K sh	—	—	0
2023-08-17	Keenova Therapeutics plcF Tax Payment	EVP & Head of Spec Generics	FTax Payment	−5,859 sh	$0.69	−$4,060.287	32,686
2023-06-30	Keenova Therapeutics plcRestricted Stock UnitsD Disposition to Issuer	EVP & Head of Spec Generics	DDisposition to Issuer	−80.8K sh	—	—	0
2023-04-03	Keenova Therapeutics plcRestricted Stock UnitsA Award	EVP & Head of Spec Generics	AAward	+80.8K sh	—	—	80,754
2023-03-13	Keenova Therapeutics plcP Purchase	EVP & Head of Spec Generics	PPurchase	+1,000 sh	$8.48	+$8,479.9	38,545
2022-12-14	Keenova Therapeutics plcA Award	EVP & Head of Spec Generics	AAward	+37.5K sh	—	—	37,545

Recent filings

Accepted (ET)
Nov 124
Welch Stephen Andrew0001104659-25-110627
SEC(opens sec.gov)
Aug 44
Welch Stephen Andrew0001104659-25-073792
SEC(opens sec.gov)
Jan 24
Welch Stephen Andrew0001104659-25-000375
SEC(opens sec.gov)
Feb 64
Welch Stephen Andrew0001104659-24-011139
SEC(opens sec.gov)
Nov 164
Welch Stephen Andrew0001104659-23-119102
SEC(opens sec.gov)
Aug 184
Welch Stephen Andrew0001104659-23-093624
SEC(opens sec.gov)
Jul 54
Welch Stephen Andrew0001104659-23-078283
SEC(opens sec.gov)
Apr 54
Welch Stephen Andrew0001104659-23-042296
SEC(opens sec.gov)
Mar 154
Welch Stephen Andrew0001104659-23-032706
SEC(opens sec.gov)
Dec 224
Welch Stephen Andrew0001104659-22-129622
SEC(opens sec.gov)

Companies

Keenova Therapeutics plcEVP & Head of Spec Generics

Address

675 MCDONNELL BLVD.

HAZELWOOD, MO, 63042